Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1

Brain-type creatine kinase (CK-BB) increases during osteoclastogenesis, with high circulating amounts in type I osteogenesis imperfecta (OI) following treatment with neridronate, a bisphosphonate able to inhibit osteoclast activity and survival. The aim of this study was to demonstrate the correlati...

Descripción completa

Detalles Bibliográficos
Autores principales: Faienza, Maria Felicia, Tummolo, Albina, Celli, Mauro, Finocchiaro, Roberto, Piacente, Laura, Di Serio, Francesca, Nicchia, Grazia Paola, Brunetti, Giacomina, D’Eufemia, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953364/
https://www.ncbi.nlm.nih.gov/pubmed/36830994
http://dx.doi.org/10.3390/biomedicines11020458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953364/
https://www.ncbi.nlm.nih.gov/pubmed/36830994
http://dx.doi.org/10.3390/biomedicines11020458

Ejemplares similares